All Stories

  1. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
  2. Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
  3. Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
  4. FP374DELETION OF VITAMIN D RECEPTOR EXCLUSIVELY IN VASCULAR SMOOTH MUSCLE CELLS PREVENTS VASCULAR CALCIFICATION
  5. Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients
  6. Functional Distribution and Regulation of the NMDAR in the Kidney, Heart and Parathyroid Gland
  7. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study
  8. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD
  9. A New Gender-Specific Formula to Estimate 24-Hour Urine Protein from Protein to Creatinine Ratio
  10. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD
  11. SP357PROGRESSION OF PERIPHERAL ARTERY DISEASE IN CHRONIC RENAL IMPAIRMENT: THE NEFRONA PROJECT
  12. FP359SUBCLINICAL PERIPHERAL ARTERY DISEASE PREDICTS CARDIOVASCULAR EVENTS IN CHRONIC RENAL IMPAIRMENT: THE NEFRONA PROJECT
  13. Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
  14. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
  15. The potential of targeting NMDA receptors outside the CNS
  16. Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals
  17. The Role of Carotid Ultrasound in Assessing Carotid Atherosclerosis in Individuals at Low-to-intermediate Cardiovascular Risk
  18. Papel de la ecografía carotídea en la reclasificación del riesgo cardiovascular de sujetos de riesgo bajo-intermedio
  19. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease
  20. How Does Vitamin D Work?
  21. Calcium Signaling in Renal Tubular Cells
  22. Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease
  23. The Physiology of Vitamin D Receptor Activation
  24. Role of vitamin D receptor activators on cardiovascular risk
  25. Vitamin D and the vasculature: can we teach an old drug new tricks?
  26. Differential Effects of Vitamin D Analogs on Vascular Calcification
  27. Vitamin D receptor polymorphisms and diseases
  28. Inhibition of Inducible Nitric Oxide Synthase Alters Thy-1 Glomeruonephritis in Rats
  29. Acute Renal Failure: Is Nitric Oxide the Bad Guy?
  30. Increased renal glomerular endothelin-1 release in gentamicin-induced nephrotoxicity
  31. Cardiovascular effects of elgodipine and nifedipine compared in anaesthetized rats
  32. Increased Glomerular Nitric Oxide Synthesis in Ischemic Acute Renal Failure in the Rat